ANL logo
ANL NASDAQ KY

Adlai Nortye Ltd. - American Depositary Shares

Healthcare · Biotechnology Website · IPO Sep 2023
$8.18
▲ +$0.28 (+3.54%)
Vol 453K
2
Quality Score
fail
Mkt Cap
$52.4M
D/E
106.83
Beta
0.70
52W
$1–$3

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Fundamentals Trend

Metric 2024-12-31 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM)
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 106.83 106.83 106.83 106.83 106.83 106.83
Current Ratio 1.41 1.41 1.41 1.41 1.41 1.41

Key Ratios

ROA (TTM)
-88.8%
P/B
3.9
EPS (TTM)
$-0.89
CF/Share
$-1.65
52W High
$2.99
52W Low
$0.88
$0.88 52-Week Range $2.99

How does ANL compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

ANL valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
3.9
58% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

ANL profitability vs Biotechnology peers

ROE
0% below peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-88.8%
90% below peers (-46.7%)
vs Peers
vs Industry
Weak

ANL financial health vs Biotechnology peers

D/E ratio
106.8
0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
1.4
68% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.7
28% below peers (1.0)
vs Peers
vs Industry
More volatile

ANL fundamentals radar

ANL Peer median Industry

ANL profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ANL vs peers: key metrics